Response to treatment with azacitidine in children with advanced myelodysplastic syndrome prior to hematopoietic stem cell transplantation

Advanced myelodysplastic syndrome harbors a high risk of progression to acute myeloid leukemia and poor prognosis. In children, there is no established treatment to prevent or delay progression to leukemia prior to hematopoietic stem cell transplantation. Azacitidine is a hypomethylating agent, whic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Haematologica
Main Authors: Waespe, Nicolas, Van Den Akker, Machiel, Klaassen, Robert J., Lieberman, Lani, Irwin, Meredith S., Ali, Salah S., Abdelhaleem, Mohamed, Zlateska, Bozana, Liebman, Mira, Cada, Michaela, Schechter, Tal, Dror, Yigal
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2016
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5479623/
https://ncbi.nlm.nih.gov/pubmed/27540140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2016.145821
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados